Hubei
300966.SZHubei Goto Biopharm Co.,Ltd. Price (300966.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
115,025,074
(0.2185)%Balance Sheet Summary
| Total Assest | |
| Total Liabilities | |
| Total Equity | |
| Total Investments | |
| Total Liabilities And Total Equ... | |
| Total debt |
Balance Sheet
Hubei Goto Biopharm Co.,Ltd.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash And Cash Equivalents | 44.07M | 65.11M | 129.66M | 28.96M | 209.91M | 438.42M | 181.97M | ||||||||||||
| Short Term Investments | 15.30M | 0.00 | 0.00 | 0.00 | 101.18k | 15.01M | 1.01k | ||||||||||||
| Net Receivables | 109.84M | 104.59M | 192.90M | 312.53M | 243.86M | 269.36M | 235.40M | ||||||||||||
| Inventory | 102.53M | 194.15M | 243.49M | 200.74M | 371.24M | 432.50M | 396.16M | ||||||||||||
| Other Current Assets | 42.97M | 66.10M | 21.59M | 37.41M | 33.14M | 58.44M | 56.20M | ||||||||||||
| Total Current Assets | 299.41M | 429.96M | 587.65M | 579.64M | 858.26M | 1.21B | 869.73M | ||||||||||||
| Non Current Assets | |||||||||||||||||||
| Property, Plant, and Equipment, Net | 167.05M | 166.55M | 201.24M | 198.11M | 257.76M | 611.57M | 1.39B | ||||||||||||
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Intangible Assets | 13.70M | 13.39M | 21.38M | 21.06M | 27.82M | 43.14M | 51.00M | ||||||||||||
| Long Term Investments | 0.00 | 1.00 | 2.00 | 2.00 | 14.37M | 33.07M | 48.23M | ||||||||||||
| Tax Assets | 2.14M | 2.80M | 3.80M | 3.43M | 8.82M | 16.91M | 22.62M | ||||||||||||
| Other Non-Current Assets | 1.03M | 2.38M | 3.61M | 2.19M | 44.22M | 149.90M | 65.26M | ||||||||||||
| Total Non-Current Assets | 183.92M | 185.12M | 230.04M | 224.78M | 352.99M | 854.59M | 1.58B | ||||||||||||
| Other Assets | 1.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 | ||||||||||||
| Total Assets | 483.34M
+0% |
615.08M
+27% |
817.68M
+33% |
804.43M
-2% |
1.21B
+51% |
2.07B
+71% |
2.45B
+18% |
||||||||||||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Account Payables | 94.90M | 94.13M | 134.22M | 74.12M | 138.17M | 205.52M | 532.24M | ||||||||||||
| Short Term Debt | 55.95M | 80.90M | 188.69M | 139.77M | 143.41M | 323.61M | 110.09M | ||||||||||||
| Tax Payables | 7.31M | 9.82M | 9.14M | 8.26M | 11.40M | 7.49M | 4.08M | ||||||||||||
| Deferred Revenue | 22.93M | 14.28M | 13.38M | 12.52M | 22.57M | 18.96M | 0.00 | ||||||||||||
| Other Current Liabilities | 18.48M | -8,355,549.00 | -90,256,720.00 | 24.79M | 36.50M | 62.43M | 39.99M | ||||||||||||
| Total Current Liabilities | 176.64M | 190.77M | 296.54M | 247.13M | 333.18M | 575.97M | 686.41M | ||||||||||||
| Non Current Liabilities | |||||||||||||||||||
| Long Term Debt | 0.00 | 8.04M | 31.51M | 1.31M | 6.67M | 441.45M | 652.91M | ||||||||||||
| Deferred Revenue Non Current | 6.24M | 8.01M | 8.37M | 7.69M | 42.98M | 69.71M | 84.33M | ||||||||||||
| Deferred Tax Liabilities Non-Current | 0.00 | -8,044,034.00 | -31,512,116.00 | -1,311,699.00 | 192.39 | 1.78k | 289.42k | ||||||||||||
| Other Non-Current Liabilities | 0.00 | 1.00 | 1.00 | 17.45M | 0.61 | -69,655,737.00 | 30.00k | ||||||||||||
| Total Non-Current Liabilities | 6.24M | 16.06M | 39.89M | 17.45M | 49.65M | 511.21M | 737.56M | ||||||||||||
| Other Liabilities | 1.00 | 0.00 | 1.00 | 1.00 | 0.00 | 0.00 | -9.00 | ||||||||||||
| Capital Lease Obligations | 0.00 | 8.04M | 72.88M | 1.31M | 6.67M | 6.39M | 538.63k | ||||||||||||
| Total Liabilities | 182.88M
+0% |
206.82M
+13% |
336.43M
+63% |
264.58M
-21% |
382.83M
+45% |
1.09B
+184% |
1.42B
+31% |
||||||||||||
| Equity | |||||||||||||||||||
| Preferred Stock | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | ||||||||||||
| Common Stock | 82.01M | 86.28M | 86.28M | 86.28M | 115.28M | 115.28M | 115.28M | ||||||||||||
| Retained Earnings | 54.33M | 76.16M | 145.48M | 197.36M | 272.81M | 297.32M | 320.34M | ||||||||||||
| Accumulated Other Comprehensive Income Loss | 9.44M | 1.89M | 5.57M | 6.98M | 9.86M | 106.37M | 108.04M | ||||||||||||
| Other Total Stockholders Equity | 154.67M | 245.82M | 243.92M | 243.92M | 409.11M | 409.11M | 409.09M | ||||||||||||
| Total Stockholders Equity | 300.45M | 408.26M | 481.25M | 534.54M | 807.05M | 928.07M | 952.75M | ||||||||||||
| Minority Interest | 0.00 | 0.00 | 0.00 | 5.31M | 21.36M | 53.07M | 71.03M | ||||||||||||
| Total Equity | 300.45M
+0% |
408.26M
+36% |
481.25M
+18% |
539.85M
+12% |
828.42M
+53% |
981.14M
+18% |
1.02B
+4% |
||||||||||||
| Total Liabilities And Total Equity | 483.34M
+0% |
615.08M
+27% |
817.68M
+33% |
804.43M
-2% |
1.21B
+51% |
2.07B
+71% |
2.45B
+18% |
||||||||||||
| Additional Metrics | |||||||||||||||||||
| Total Investments | 15.30M
+0% |
1.00
-100% |
2.00
+100% |
2.00
+0% |
14.47M
+723,575,500% |
48.08M
+232% |
48.24M
+0% |
||||||||||||
| Total Debt | 55.95M
+0% |
80.90M
+45% |
147.32M
+82% |
139.77M
-5% |
161.54M
+16% |
770.30M
+377% |
763.01M
-1% |
||||||||||||
| Net Debt | 11.88M | 15.78M | 17.66M | 110.80M | -48,372,704.00 | 331.88M | 581.03M | ||||||||||||